Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.51)
# 1,013
Out of 4,423 analysts
569
Total ratings
49.8%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintained: Buy | $155 → $156 | $127.06 | +22.78% | 44 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,445 → $1,194 | $1,144.84 | +4.29% | 28 | May 11, 2026 | |
| NTRA Natera | Maintained: Buy | $257 → $265 | $231.41 | +14.52% | 41 | May 8, 2026 | |
| GH Guardant Health | Maintained: Buy | $120 → $129 | $131.78 | -2.11% | 2 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $28 → $22 | $18.47 | +19.11% | 3 | May 8, 2026 | |
| TECH Bio-Techne | Maintained: Hold | $70 → $49 | $57.94 | -15.43% | 42 | May 7, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $44 → $43 | $21.12 | +103.60% | 46 | May 7, 2026 | |
| WAT Waters | Maintained: Buy | $363 → $387 | $355.44 | +8.88% | 44 | May 6, 2026 | |
| GRAL GRAIL | Maintained: Buy | $82 → $70 | $63.74 | +9.82% | 2 | May 6, 2026 | |
| TEM Tempus AI | Maintained: Buy | $68 → $59 | $50.84 | +16.05% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $65 | $87.56 | -25.77% | 46 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $129 → $117 | $100.00 | +17.00% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $53 → $43 | $36.95 | +16.37% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $653 → $639 | $464.61 | +37.53% | 56 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $249 → $245 | $177.17 | +38.29% | 30 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $3 | $5.20 | -42.31% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $9.58 | +14.82% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $137 | $161.93 | -15.40% | 54 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 | $98.32 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $2.70 | n/a | 11 | Nov 2, 2018 |
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $155 → $156
Current: $127.06
Upside: +22.78%
Mettler-Toledo International
May 11, 2026
Maintained: Hold
Price Target: $1,445 → $1,194
Current: $1,144.84
Upside: +4.29%
Natera
May 8, 2026
Maintained: Buy
Price Target: $257 → $265
Current: $231.41
Upside: +14.52%
Guardant Health
May 8, 2026
Maintained: Buy
Price Target: $120 → $129
Current: $131.78
Upside: -2.11%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $28 → $22
Current: $18.47
Upside: +19.11%
Bio-Techne
May 7, 2026
Maintained: Hold
Price Target: $70 → $49
Current: $57.94
Upside: -15.43%
Castle Biosciences
May 7, 2026
Maintained: Buy
Price Target: $44 → $43
Current: $21.12
Upside: +103.60%
Waters
May 6, 2026
Maintained: Buy
Price Target: $363 → $387
Current: $355.44
Upside: +8.88%
GRAIL
May 6, 2026
Maintained: Buy
Price Target: $82 → $70
Current: $63.74
Upside: +9.82%
Tempus AI
May 6, 2026
Maintained: Buy
Price Target: $68 → $59
Current: $50.84
Upside: +16.05%
May 5, 2026
Maintained: Buy
Price Target: $50 → $65
Current: $87.56
Upside: -25.77%
May 4, 2026
Maintained: Buy
Price Target: $129 → $117
Current: $100.00
Upside: +17.00%
Apr 29, 2026
Upgraded: Buy
Price Target: $53 → $43
Current: $36.95
Upside: +16.37%
Apr 24, 2026
Maintained: Buy
Price Target: $653 → $639
Current: $464.61
Upside: +37.53%
Apr 22, 2026
Maintained: Buy
Price Target: $249 → $245
Current: $177.17
Upside: +38.29%
Feb 26, 2026
Maintained: Hold
Price Target: $2 → $3
Current: $5.20
Upside: -42.31%
Feb 12, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $9.58
Upside: +14.82%
Feb 6, 2026
Maintained: Hold
Price Target: $109 → $137
Current: $161.93
Upside: -15.40%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 4, 2019
Maintained: Buy
Price Target: $102
Current: $98.32
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $9 → $8
Current: $2.70
Upside: n/a